By Market & Region

SHERIDAN, WYOMING – October 15, 2025 – Eli Lilly’s investigational oral GLP-1 receptor agonist, orforglipron, has achieved another major milestone in its late-stage clinical program. Following its earlier success against Novo Nordisk’s semaglutide, the once-daily oral therapy has now demonstrated superiority over AstraZeneca’s blockbuster Farxiga (dapagliflozin) in two Phase III studies targeting patients with inadequately controlled type 2 diabetes.

Strong Phase III Results Reinforce Competitive Edge
The twin trials, ACHIEVE-2 and ACHIEVE-5, assessed orforglipron’s efficacy and safety in patients whose diabetes remained poorly controlled despite metformin therapy. Both studies met their primary and secondary endpoints, showing significant improvements in key glycemic markers and body weight after 40 weeks of treatment.

SHERIDAN, WYOMING – October 15, 2025 – Sarepta Therapeutics is pressing forward with its limb-girdle muscular dystrophy (LGMD) gene therapy, SRP-9003, despite a strategic pivot earlier this year toward small interfering RNA (siRNA) therapies and ongoing regulatory challenges. New late-stage data presented at the World Muscle Society Congress in Vienna suggest the therapy could still hold clinical and commercial potential—if Sarepta can navigate FDA scrutiny and rebuild trust in its gene therapy platform.

Promising Clinical Outcomes at WMS 2025
At the 30th annual World Muscle Society (WMS) meeting, Sarepta shared Phase III data from its EMERGENE trial evaluating SRP-9003 in 17 LGMD patients. The therapy, designed to restore beta-sarcoglycan expression—a key muscle-stabilizing protein—met its primary endpoint after 60 days of observation.

SHERIDAN, WYOMING – October 15, 2025 – Pelage Pharmaceuticals has raised $120 million in Series B financing to advance its novel stem cell–activating therapy for hair loss into Phase III clinical trials. The funding positions the California-based biotech to accelerate clinical development of PP405, a first-in-class topical molecule designed to rejuvenate dormant hair follicle stem cells and restore natural hair growth.

SHERIDAN, WYOMING – October 15, 2025 – Boehringer Ingelheim is continuing its high-stakes investment strategy in next-generation oncology treatments, signing a deal worth up to $991 million with South Korea’s AimedBio to license an antibody-drug conjugate (ADC) for cancer. The move underscores Boehringer’s accelerating focus on precision oncology and reinforces its growing footprint in the ADC space—one of the most competitive frontiers in cancer therapeutics.

SHERIDAN, WYOMING – October 15, 2025 – Bristol Myers Squibb (BMS) has expanded its artificial intelligence-driven collaboration with insitro, reinforcing its long-term strategy to accelerate therapeutic development in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). The renewed deal underscores a shared commitment to leveraging AI and advanced chemistry platforms to unlock new pathways in ALS drug discovery.

AI-Powered Extension Strengthens a Five-Year Alliance

The latest extension adds another year to the 2020 collaboration, with BMS investing up to $20 million to continue joint research using insitro’s advanced ChemML platform. The total deal value could exceed $2 billion through potential discovery, development, and commercial milestones, as well as royalties on any approved therapies.

SHERIDAN, WYOMING – October 15, 2025 – BioCryst Pharmaceuticals is strengthening its hereditary angioedema (HAE) pipeline through the acquisition of Massachusetts-based Astria Therapeutics in a $700 million cash-and-stock deal. The move positions BioCryst to compete more aggressively in the rare disease market by combining its oral HAE treatment, Orladeyo, with Astria’s long-acting injectable candidate, navenibart.

Strategic Expansion into Injectable HAE Therapy
The acquisition gives BioCryst a promising investigational monoclonal antibody, navenibart, currently in Phase III trials for HAE prophylaxis. Designed to inhibit plasma kallikrein — a key driver of HAE attacks — the therapy could offer significant convenience and efficacy improvements over existing injectable options.

SHERIDAN, WYOMING – October 15, 2025 – In a pivotal development for the U.S. biotech sector, Krystal Biotech has received the U.S. Food and Drug Administration’s (FDA) second-ever platform technology designation for its non-replicating HSV-1 viral vector—positioning the company as a key early beneficiary of the agency’s emerging regulatory framework for gene therapy platforms.

Validation of a Versatile Gene Delivery Platform

The FDA’s platform designation recognizes Krystal’s HSV-1 vector technology as a “well-understood and reproducible” delivery system capable of supporting multiple gene therapy programs. Analysts at William Blair described Krystal as “poised to be the first major beneficiary” of this program, highlighting the FDA’s confidence in the HSV-1 vector’s cross-program applicability.

SHERIDAN, WYOMING – October 15, 2025 – Heidelberger Druckmaschinen AG (HEIDELBERG) and China’s MK Masterwork are deepening their decade-long collaboration to advance automation and robotics in packaging production. The renewed strategic partnership, announced at a joint anniversary event in Tianjin, underscores both companies’ commitment to delivering integrated, end-to-end solutions for the global packaging and printing industry.

A Decade of Partnership Strengthening Global Reach

Since entering a strategic sales agreement in 2015, HEIDELBERG has distributed MK Masterwork’s high-performance finishing systems—including die-cutters, folding carton gluers, and hot-foil stamping machines—outside of China. Over the past decade, approximately 1,500 systems have been installed worldwide, supporting packaging manufacturers in achieving higher efficiency and throughput.

SHERIDAN, WYOMING – October 15, 2025 – Heidelberger Druckmaschinen AG (HEIDELBERG) brought together more than 200 global industry leaders at its new SHIFT 2025 summit to address one of the printing sector’s most pressing challenges: how to remain competitive amid rising costs, labor shortages, and increasingly fragmented order structures. The event underscored the company’s commitment to driving end-to-end process digitization, automation, and hybrid print production through its evolving Prinect workflow platform and AI-supported solutions like Prinect Touch Free.

SHERIDAN, WYOMING – October 15, 2025 – At Labelexpo Europe 2025 in Barcelona, Gallus and Heidelberger Druckmaschinen AG (HEIDELBERG) unveiled a next-generation suite of digital and hybrid label printing technologies designed to accelerate digital adoption across the global label industry. With the introduction of the Gallus Five and Gallus Alpha presses—alongside a new Gallus Print Academy—the companies are positioning themselves at the forefront of connected, high-performance printing for converters seeking flexibility, cost efficiency, and industrial productivity.

Hybrid and Digital Innovation to Drive Industry Transition

SHERIDAN, WYOMING – October 15, 2025 – Heidelberger Druckmaschinen AG (HEIDELBERG) and Solenis are redefining the future of sustainable packaging with a newly developed inline process that applies functional barrier coatings directly within the flexographic printing workflow. The innovation, integrated into HEIDELBERG’s high-volume Boardmaster system, aims to make paper-based flexible packaging a viable and economical alternative to plastic — accelerating the “paperization” trend across the global packaging industry.

Driving Sustainability Through Technological Integration

SHERIDAN, WYOMING – October 15, 2025 – EGGER, a leading European manufacturer of wood-based materials, has launched DecoWall, an innovative wall panel system that combines sustainable engineering with design flexibility for residential and commercial interiors. Designed to meet the growing demand for eco-conscious and easy-to-install wall solutions, DecoWall merges technical performance with aesthetic appeal — making it ideal for professional installers, architects, and designers seeking both function and form.

EGGER’s Decorative Collection 24+ Elevates Interior Design with Expanded Decors, Textures, and Digital Services

SHERIDAN, WYOMING – October 15, 2025 – EGGER has unveiled The Decorative Collection 24+, a comprehensive update to its renowned design portfolio, offering architects, interior designers, and furniture manufacturers an expanded range of materials, textures, and digital tools that redefine design flexibility. The new collection emphasizes connected solutions, sustainability, and digital integration, empowering professionals to streamline creative workflows while maintaining aesthetic precision.

SHERIDAN, WYOMING – October 15, 2025 – Globus Medical, Inc. (NYSE: GMED), a global leader in musculoskeletal innovation, has introduced the ANTHEM™ Elbow Fracture System, a next-generation plating portfolio designed to simplify complex elbow trauma repair while enhancing surgical precision and outcomes.

Advancing Orthopedic Trauma Care with Comprehensive Fixation Options
The ANTHEM™ Elbow Fracture System provides orthopedic surgeons with a complete suite of anatomically contoured plates tailored to address a broad range of fracture types—including distal humerus, proximal ulna, proximal radius, and coronoid fractures. The platform integrates 14 plate families, 2.7mm and 3.5mm screw options, and anatomy-specific reduction instruments, enabling clinicians to customize fixation strategies to each patient’s unique fracture pattern.

SHERIDAN, WYOMING – October 10, 2025 – Dentsply Sirona used DS World 2025 in Las Vegas to spotlight how an integrated, cloud-connected CEREC ecosystem—spanning AI proposals, compact milling, and next-gen materials—can compress treatment timelines and streamline digital workflows for general dentists and specialists. Marking the system’s 40th anniversary, the company paired product news with education and leadership content aimed at accelerating real-world adoption of chairside CAD/CAM.

Connected Dentistry moves from concept to routine workflow

At the core of the update is tighter alignment between CEREC and DS Core. Clinicians can access AI-assisted margin and design proposals for common indications (crowns, inlays, onlays) directly in the cloud platform, opening up:

SHERIDAN, WYOMING – October 9, 2025 – K 2025 will again make Düsseldorf the center of gravity for plastics and rubber next week, and “Rubber Street” in Hall 6 is set to be one of the show’s most concentrated hubs for elastomer innovation. Jointly organized by the German Rubber Manufacturers Association (wdk) and Messe Düsseldorf, the dedicated zone brings the full elastomer value chain into one 500 m² area—showcasing materials, compounding, processing, testing, and recycling with a sharper emphasis on thermoplastic elastomers (TPE) and circularity.

SHERIDAN, WYOMING – October 9, 2025 – K 2025 will again dedicate a packed Start-up Zone to young companies pushing the plastics and rubber industry toward data-driven efficiency and lower-carbon production, signaling where plant investments and supplier partnerships are headed this year in Düsseldorf.

Innovation focus: AI, analytics and circular economy take center stage

The Start-up Zone returns as a curated arena for early-stage technologies with direct plant-floor impact. Located in Hall 7 and fully subscribed with 20 exhibitors, the area concentrates on artificial intelligence, data exchange, biobased materials, and digitally supported production—capabilities buyers increasingly seek to meet quality, compliance, and sustainability objectives. A Start-up Pitch on Monday, October 13, 2025, will give selected founders a fast track to prospective partners on the show floor.

SHERIDAN, WYOMING – October 7, 2025 – Greek manufacturer Stohos Foods will present a refreshed frozen Greek street food and fried chicken portfolio at Anuga 2025 (Hall 4.2, Stand A31), targeting foodservice distributors, quick-service brands, and convenience retail looking for scalable, ready-to-cook SKUs. The exhibitor’s 2025 catalogues span gyros, meze, burgers, bakery and poultry platforms designed to standardize taste and throughput across multi-unit operations. (Instagram)

SHERIDAN, WYOMING – October 7, 2025 – Greek confectioner Chrisanthidis Delights will showcase a broad dessert portfolio at Anuga 2025 (Hall 3.2, Stand A70), positioning classic Mediterranean patisserie alongside on-trend cakes and cheesecakes for international retail and foodservice buyers. The line spans syruped phyllo specialties, layered cakes, and modern parfait-style desserts—an assortment aimed at category managers seeking premium taste with consistent execution across channels.

SHERIDAN, WYOMING – September 14, 2025 – The Fraunhofer Institute for Integrated Circuits IIS is spearheading large-scale practical trials in Bavaria to reimagine the future of eldercare through digital assistants, connected devices, and smart environments. With Germany projected to face a shortfall of at least 280,000 nursing staff by 2049, the “Pflege 2030” (Care 2030) project aims to alleviate workforce pressure while improving the quality of patient interaction.

Smart Technologies Selected by Caregivers
Unlike traditional top-down innovation rollouts, the Care 2030 program puts nurses in charge of technology adoption. Staff at the Karlsfeld-based “Haus Curanum” selected ten solutions to trial, reflecting their day-to-day needs. At the top of their list was not robotics, but a voice-controlled tablet for speech-to-text patient documentation, eliminating manual entry on wired PCs.

Other requested tools include: